Canaccord Genuity Group (TSE:CF – Free Report) had its price target raised by TD Securities from C$10.00 to C$12.00 in a ...

Canaccord Genuity Group (TSE:CF – Free Report) had its target price lifted by Cormark from C$11.50 to C$12.50 in a report issued on Tuesday,BayStreet.CA reports. Cormark also issued estimates for ...

On Wednesday, Blend Labs Inc (BLND) stock saw a decline, ending the day at $4.36 which represents a decrease of $-0.19 or -4.18% from the prior close of $4.55. The stock opened at $4.59 and touched a ...

Fintel reports that on November 13, 2024, Canaccord Genuity upgraded their outlook for Viant Technology (NasdaqGS:DSP) from ...

Fintel reports that on November 13, 2024, Canaccord Genuity downgraded their outlook for Doximity (NYSE:DOCS) from Buy to ...

ROCKAWAY, N.J., Nov. 14, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness ...

Canaccord Genuity Group Inc. recorded strong growth in wealth-management and capital-markets divisions for its fiscal second ...

Firm-wide Revenue: $128 million for the quarter, up 27% year-over-year. Fiscal Year-to-Date Revenue: $857 million, up 26% ...

Analysts at Canaccord Genuity lowered their target price on shipbroking services business Braemar from 410.0p to 380.0p on ...

Good morning, ladies and gentlemen. Thank you for standing by. I'd like to welcome everyone to the Canaccord Genuity Group Inc. Fiscal 2025 Second Quarter Results Conference Call. All lines have been ...

About Elutia Elutia develops and commercializes drug-eluting biomatrix products to improve compatibility between medical devices and the patients who need them. With a growing population in need of ...